ag-1296 has been researched along with Carcinoma, Small Cell in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krystal, GW | 1 |
| Carlson, P | 1 |
| Litz, J | 1 |
1 other study available for ag-1296 and Carcinoma, Small Cell
| Article | Year |
|---|---|
Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins.
Topics: Apoptosis; Carcinoma, Small Cell; Cell Division; DNA Fragmentation; Dose-Response Relationship, Drug | 1997 |